IGM Biosciences (IGMS) Earnings Date, Estimates & Call Transcripts $17.93 +2.26 (+14.42%) (As of 01:36 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateNov. 11EstimatedActual EPS (Aug. 14) -$0.79 Missed By -$0.97 Consensus EPS (Aug. 14) $0.18 Earnings Press Release Get IGM Biosciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for IGMS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIGMS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IGMS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. IGM Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242($0.81)($0.75)($0.78) Q2 20242($0.79)($0.76)($0.78) Q3 20242($0.83)($0.82)($0.83) Q4 20242($0.84)($0.71)($0.78) FY 20248($3.27)($3.04)($3.16) Q1 20252($0.85)($0.46)($0.66) Q2 20252($0.88)($0.38)($0.63) Q3 20252($0.90)($0.40)($0.65) Q4 20252($0.93)($0.40)($0.67) FY 20258($3.56)($1.64) ($2.60)IGMS Earnings Date and InformationIGM Biosciences last released its earnings results on August 14th, 2024. The reported ($0.79) earnings per share for the quarter, missing analysts' consensus estimates of $0.18 by $0.97. The company had revenue of $1.25 million for the quarter, compared to analysts' expectations of $51.75 million. IGM Biosciences has generated ($4.31) earnings per share over the last year (($4.31) diluted earnings per share). Earnings for IGM Biosciences are expected to grow in the coming year, from ($3.17) to ($2.59) per share. IGM Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off prior year's report dates.Read More IGM Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/11/2024(Estimated)------- 8/14/2024-$0.18($0.79)($0.97)($0.79)$51.75 million$1.25 million 5/8/2024Q1 2024($0.84)($0.83)+$0.01($0.83)$0.71 million$0.50 million 3/7/2024Q4 2023($1.06)($1.01)+$0.05($1.01)$0.95 million$0.65 million 11/13/2023Q3 2023($1.25)($1.04)+$0.21($1.04)$0.73 million$0.51 million8/3/2023Q2 2023($1.40)($1.43)($0.03)($1.43)$0.80 million$0.45 million 5/12/2023Q1 2023($1.37)($1.33)+$0.04($1.33)$1.79 million$0.52 million Get the Latest News and Ratings for IGMS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IGM Biosciences and its competitors with MarketBeat's FREE daily newsletter. 3/30/2023Q4 2022($1.53)($1.19)+$0.34($1.19)$15.27 million$0.37 million 11/3/2022Q3 2022($1.45)($1.32)+$0.13($1.32)$0.39 million$0.33 million 8/8/2022Q2 2022($1.44)($1.33)+$0.11($1.33)$38.91 million$0.37 million 5/9/2022Q1 2022($1.65)($1.53)+$0.12($1.53)-- 3/29/2022Q4 2021($1.58)($1.50)+$0.08($1.50)-- 11/4/2021Q3 2021($1.33)($1.32)+$0.01($1.32)-- 8/8/2021Q2 2021($1.16)($1.16)-($1.16)-- 5/6/2021Q1 2021($0.98)($0.95)+$0.03($0.95)-- 3/29/2021Q4 2020($0.74)($0.79)($0.05)($0.79)-- 11/5/2020Q3 2020($0.69)($0.66)+$0.03($0.66)-- 8/6/2020Q2 2020($0.65)($0.62)+$0.03($0.62)-- 5/7/2020Q1 2020($0.55)($0.58)($0.03)($0.58)-- 3/26/2020Q4 2019($0.44)($0.49)($0.05)($0.49)-- 11/7/2019Q3($1.09)($2.41)($1.32)($2.41)-- IGM Biosciences Earnings - Frequently Asked Questions When is IGM Biosciences's earnings date? IGM Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates. Learn more on IGMS's earnings history. Did IGM Biosciences beat their earnings estimates last quarter? In the previous quarter, IGM Biosciences (NASDAQ:IGMS) missed the analysts' consensus estimate of $0.18 by $0.97 with a reported earnings per share (EPS) of ($0.79). Learn more on analysts' earnings estimate vs. IGMS's actual earnings. How much revenue does IGM Biosciences generate each year? IGM Biosciences (NASDAQ:IGMS) has a recorded annual revenue of $2.91 million. How much profit does IGM Biosciences generate each year? IGM Biosciences (NASDAQ:IGMS) has a recorded net income of -$246.42 million. IGMS has generated -$4.31 earnings per share over the last four quarters. What is IGM Biosciences's EPS forecast for next year? IGM Biosciences's earnings are expected to grow from ($3.17) per share to ($2.59) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies AUPH Earnings Results XNCR Earnings Results CYRX Earnings Results ZNTL Earnings Results APLS Earnings Results APGE Earnings Results RYTM Earnings Results EWTX Earnings Results XENE Earnings Results MLTX Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Taiwan Semiconductor Soars on Earnings With More Room to RunBank of America Earnings Uncover Shifts in Consumer SpendingGoldman Sachs Earnings Reveal Market Moves Investors Can't IgnoreNike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth? This page (NASDAQ:IGMS) was last updated on 10/22/2024 by MarketBeat.com Staff From Our PartnersMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredAfter calling a 2,269% gain, here’s his NEXT tradeReady for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored[SHOCKING] Crypto Document Leak…The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around th...Crypto 101 Media | SponsoredHow a $200,000 Mistake Unlocked a $118 Billion Gold TreasureThe window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.Monument Traders Alliance | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGM Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGM Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.